Allergy Asthma Clin Immunol:辅酶Q10对过敏性鼻炎和过敏性哮喘的影响

2021-04-12 AlexYang MedSci原创

过敏性哮喘是一种持续或间歇性接触过敏原而引起的炎症性疾病,过敏性鼻炎可成为哮喘的诱发因素。这些疾病的主要机制是过敏反应和免疫反应失调。辅酶Q10是线粒体中的一种酶辅助因子,能够控制哮喘和过敏性鼻炎症状

过敏性哮喘是一种持续或间歇性接触过敏原而引起的炎症性疾病,过敏性鼻炎可成为哮喘的诱发因素。这些疾病的主要机制是过敏反应和免疫反应失调。辅酶Q10是线粒体中的一种酶辅助因子,能够控制哮喘和过敏性鼻炎症状

最近,有研究人员确定了CoQ10诱导的抗过敏作用是由Nrf2的上调介导的

研究人员首先建立了过敏性鼻炎和过敏性哮喘动物模型,并使用Co-Q10、Co-Q10和O-3、Co-Q10和Mg-S治疗。他们收集了动物模型的支气管肺泡灌洗液,测定了IL-4、5、13、INF-y、Eicosanoids、IgE、EPO和组织胺的产生情况。同时,还研究了COX-2、CCL24、CCL11、Nrf2、Eotaxin、Cytb、COX1和ND1基因的表达和组织病理学。结果发现,Co-Q10与两种补充剂(Mg-S和O-3)能够调节MRC、BALf嗜酸性粒细胞、嗜酸性炎症相关基因(eotaxin、CCL11和CCL24)、支气管周围和血管周围炎症、EPO、2型细胞因子(IL-4、5和13)、IgE、组胺、Cyc-LT和LTB4等主要过敏生物因子。重要的是,Co-Q10治疗增加了Nrf2的表达和Nrf2诱导的抗氧化基因、谷胱甘肽氧化还原,抑制了炎症、氧化应激损伤、Th2细胞因子的产生,减轻了过敏性炎症反应。

所有组的肺部组织切片染色分析

最后,研究人员指出,Nrf2在过敏原的作用下被激活,并预防鼻炎和哮喘的发展,在支气管保护中起着重要作用。另外,辅酶Q10能增加Nrf2的表达,而Nrf2的过表达对控制2型细胞因子、过敏介质和炎症因子有很强的作用

原始出处:

Qixue Du , Wei Meng , Seyyed Shamsadin Athari et al. The effect of Co-Q10 on allergic rhinitis and allergic asthma. Allergy Asthma Clin Immunol. Mar 2021

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-07-31 drwjr
  2. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-07-11 skhzy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-04-14 膀胱癌
  6. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-04-13 zy&kt

    学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-04-12 ms2000001361349190

    好东西

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-04-12 12584d3cm01暂无昵称

    学习了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1716497, encodeId=888d1e16497dc, content=<a href='/topic/show?id=be3193e20cd' target=_blank style='color:#2F92EE;'>#辅酶Q10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93720, encryptionId=be3193e20cd, topicName=辅酶Q10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=104f32235338, createdName=drwjr, createdTime=Sat Jul 31 06:13:27 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977169, encodeId=d36619e716961, content=<a href='/topic/show?id=0081289832' target=_blank style='color:#2F92EE;'>#asthma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2898, encryptionId=0081289832, topicName=asthma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Sun Jul 11 22:13:27 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1712763, encodeId=e3971e127632e, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Mar 20 03:13:27 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047400, encodeId=0b33204e40021, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jan 06 11:13:27 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329487, encodeId=fd3d132948ec4, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499959, encodeId=cc0d1499959f1, content=<a href='/topic/show?id=fcf094038bb' target=_blank style='color:#2F92EE;'>#过敏性哮喘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94038, encryptionId=fcf094038bb, topicName=过敏性哮喘)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a19396608, createdName=wodejia-dayu, createdTime=Wed Apr 14 06:13:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956419, encodeId=5810956419d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Apr 13 01:27:02 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956398, encodeId=24329563986c, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Mon Apr 12 23:37:38 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956178, encodeId=ebc69561e853, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:33:08 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956171, encodeId=935c9561e146, content=辅酶Q10还有这种作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=A55F426F0ACD7AD8AE0663582B47A53D, createdBy=33115465098, createdName=ms6000000603082467, createdTime=Mon Apr 12 15:22:20 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-04-12 ms6000000603082467

    辅酶Q10还有这种作用

    0

相关资讯

Respir Res:母乳喂养时间能够改变新生儿和家族风险因素对儿童哮喘和过敏的影响

儿童哮喘和过敏性疾病是一个严重的全球性问题。关于分娩方式、家庭中孩子的数量和母乳喂养与儿童哮喘和过敏性疾病的关联性发现并不一致。最近,有研究人员评估了这些关联,并调查了母乳喂养是否改变了新生儿和家族性

J Allergy Clin Immunol Pract:Dupilumab可改善中重度特应性皮炎成人的哮喘和鼻窦炎疗效

在中重度特应性皮炎(AD)患者的临床试验中,Dupilumab具有疗效,且安全性可接受。最近,有研究人员在4项随机、双盲、安慰剂对照试验中评估了Dupilumab对中度至重度AD成年患者哮喘和鼻窦状况

Clin Exp Allergy:季节性过敏性鼻炎患者下呼吸道中IL-33表达增加且与天然过敏原暴露无关

在过敏性哮喘患者中,参与2型气道炎症发展的IL-33通路被激活。根据 "同一气道,同一疾病 "的概念,IL-33通路在过敏性鼻炎患者的气道中也应被激活。

哮喘新药显功效!tezepelumab将病情加重风险降低了56%

TSLP靶向单克隆抗体tezepelumab已达到该试验的主要终点。

撸猫有风险!抗体鸡尾酒REGN1908-1909治疗猫过敏性轻度哮喘,II期研究取得阳性结果

该试验达到了预防早期哮喘反应的主要终点(EAR,定义为一秒钟内强制呼气量下降≥20%[FEV1])。